Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease | MicrobiomeTrials← Back to trialsNCT07619547
Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-09-15Est. Completion: 2036-06-01
Enrollment target: 100 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Obesity (Disorder)
This randomized crossover clinical trial aims to evaluate the effect of a synbiotic containing Lactobacillus acidophilus…
Huixquilucan, MexicoEst. completion Feb 2, 2027
Gastrointestinal Disease Symptoms
The aim of this study is to determine how regular consumption of Synbiotic+, a dietary supplement that contains prebioti…
Fort Collins, United StatesCompleted Aug 1, 2026